English
简体中文
Total: £ 56.28
Published Date: 2025-09-11 | Pages: 79 | Tables: 79 | Medical Devices & Consumables
The global Gene Fragment market size was US$ 327 million in 2024 and is forecast to a readjusted size of US$ 689 million by 2031 with a CAGR of 11.4% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Gene Fragment market competitiveness, regional economic performance, and supply chain configurations.
Gene fragments are pieces of genes containing only the exons (those parts of the gene which actually encode the protein sequence). They are composed of cDNA. Gene Fragment can be used in CRISPR-Based Genome Editing, Recombinant Antibody Engineering, cloning process, qPCR and PCR Controls, Enzyme Engineering, Vaccine Research, High Resolution Melt (HRM) Assays etc field.
Global key players of gene fragment include Integrated DNA Technologies, Thermo Scientific, Eurofins Scientific, GenScript Biotech, Azenta Life Sciences, etc. The top five players hold a share over 70%. North America is the largest market, has a share about 40%, followed by Asia-Pacific, and Europe, with share 29% and 25%, separately.
The global Gene Fragment market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Integrated DNA Technologies
Thermo Scientific
Eurofins Scientific
GenScript Biotech
Azenta Life Sciences
Twist Bioscience
Synbio Technologies
Bio Basic
BiOligo Biotechnology
By Type: (Dominant Segment vs High-Margin Innovation)
0-999 bp
1000-1999 bp
2000-3999 bp
4000+ bp
By Application: (Core Demand Driver vs Emerging Opportunity)
CRISPR-based Genome Editing
Antibody Engineering
Cloning Process
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Integrated DNA Technologies in Europe)
- Emerging Product Trends: 0-999 bp adoption vs. 1000-1999 bp premiumization
- Demand-Side Dynamics: CRISPR-based Genome Editing growth in China vs. Antibody Engineering potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Gene Fragment market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., 1000-1999 bp in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Antibody Engineering in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Gene Fragment value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Gene Fragment Product Scope
1.2 Gene Fragment by Type
1.2.1 Global Gene Fragment Sales by Type (2020 & 2024 & 2031)
1.2.2 0-999 bp
1.2.3 1000-1999 bp
1.2.4 2000-3999 bp
1.2.5 4000+ bp
1.3 Gene Fragment by Application
1.3.1 Global Gene Fragment Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 CRISPR-based Genome Editing
1.3.3 Antibody Engineering
1.3.4 Cloning Process
1.3.5 Others
1.4 Global Gene Fragment Market Estimates and Forecasts (2020-2031)
1.4.1 Global Gene Fragment Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Gene Fragment Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Gene Fragment Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Gene Fragment Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Gene Fragment Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Gene Fragment Sales Market Share by Region (2020-2025)
2.2.2 Global Gene Fragment Revenue Market Share by Region (2020-2025)
2.3 Global Gene Fragment Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Gene Fragment Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Gene Fragment Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Gene Fragment Market Size and Prospective (2020-2031)
2.4.2 Europe Gene Fragment Market Size and Prospective (2020-2031)
2.4.3 China Gene Fragment Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Gene Fragment Historic Market Review by Type (2020-2025)
3.1.1 Global Gene Fragment Sales by Type (2020-2025)
3.1.2 Global Gene Fragment Revenue by Type (2020-2025)
3.1.3 Global Gene Fragment Price by Type (2020-2025)
3.2 Global Gene Fragment Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Gene Fragment Sales Forecast by Type (2026-2031)
3.2.2 Global Gene Fragment Revenue Forecast by Type (2026-2031)
3.2.3 Global Gene Fragment Price Forecast by Type (2026-2031)
3.3 Different Types Gene Fragment Representative Players
4 Global Market Size by Application
4.1 Global Gene Fragment Historic Market Review by Application (2020-2025)
4.1.1 Global Gene Fragment Sales by Application (2020-2025)
4.1.2 Global Gene Fragment Revenue by Application (2020-2025)
4.1.3 Global Gene Fragment Price by Application (2020-2025)
4.2 Global Gene Fragment Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Gene Fragment Sales Forecast by Application (2026-2031)
4.2.2 Global Gene Fragment Revenue Forecast by Application (2026-2031)
4.2.3 Global Gene Fragment Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Gene Fragment Application
5 Competition Landscape by Players
5.1 Global Gene Fragment Sales by Players (2020-2025)
5.2 Global Top Gene Fragment Players by Revenue (2020-2025)
5.3 Global Gene Fragment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Fragment as of 2024)
5.4 Global Gene Fragment Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Gene Fragment, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Gene Fragment, Product Type & Application
5.7 Global Key Manufacturers of Gene Fragment, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Gene Fragment Sales by Company
6.1.1.1 North America Gene Fragment Sales by Company (2020-2025)
6.1.1.2 North America Gene Fragment Revenue by Company (2020-2025)
6.1.2 North America Gene Fragment Sales Breakdown by Type (2020-2025)
6.1.3 North America Gene Fragment Sales Breakdown by Application (2020-2025)
6.1.4 North America Gene Fragment Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Gene Fragment Sales by Company
6.2.1.1 Europe Gene Fragment Sales by Company (2020-2025)
6.2.1.2 Europe Gene Fragment Revenue by Company (2020-2025)
6.2.2 Europe Gene Fragment Sales Breakdown by Type (2020-2025)
6.2.3 Europe Gene Fragment Sales Breakdown by Application (2020-2025)
6.2.4 Europe Gene Fragment Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Gene Fragment Sales by Company
6.3.1.1 China Gene Fragment Sales by Company (2020-2025)
6.3.1.2 China Gene Fragment Revenue by Company (2020-2025)
6.3.2 China Gene Fragment Sales Breakdown by Type (2020-2025)
6.3.3 China Gene Fragment Sales Breakdown by Application (2020-2025)
6.3.4 China Gene Fragment Major Customer
6.3.5 China Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Integrated DNA Technologies
7.1.1 Integrated DNA Technologies Company Information
7.1.2 Integrated DNA Technologies Business Overview
7.1.3 Integrated DNA Technologies Gene Fragment Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Integrated DNA Technologies Gene Fragment Products Offered
7.1.5 Integrated DNA Technologies Recent Development
7.2 Thermo Scientific
7.2.1 Thermo Scientific Company Information
7.2.2 Thermo Scientific Business Overview
7.2.3 Thermo Scientific Gene Fragment Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Thermo Scientific Gene Fragment Products Offered
7.2.5 Thermo Scientific Recent Development
7.3 Eurofins Scientific
7.3.1 Eurofins Scientific Company Information
7.3.2 Eurofins Scientific Business Overview
7.3.3 Eurofins Scientific Gene Fragment Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Eurofins Scientific Gene Fragment Products Offered
7.3.5 Eurofins Scientific Recent Development
7.4 GenScript Biotech
7.4.1 GenScript Biotech Company Information
7.4.2 GenScript Biotech Business Overview
7.4.3 GenScript Biotech Gene Fragment Sales, Revenue and Gross Margin (2020-2025)
7.4.4 GenScript Biotech Gene Fragment Products Offered
7.4.5 GenScript Biotech Recent Development
7.5 Azenta Life Sciences
7.5.1 Azenta Life Sciences Company Information
7.5.2 Azenta Life Sciences Business Overview
7.5.3 Azenta Life Sciences Gene Fragment Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Azenta Life Sciences Gene Fragment Products Offered
7.5.5 Azenta Life Sciences Recent Development
7.6 Twist Bioscience
7.6.1 Twist Bioscience Company Information
7.6.2 Twist Bioscience Business Overview
7.6.3 Twist Bioscience Gene Fragment Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Twist Bioscience Gene Fragment Products Offered
7.6.5 Twist Bioscience Recent Development
7.7 Synbio Technologies
7.7.1 Synbio Technologies Company Information
7.7.2 Synbio Technologies Business Overview
7.7.3 Synbio Technologies Gene Fragment Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Synbio Technologies Gene Fragment Products Offered
7.7.5 Synbio Technologies Recent Development
7.8 Bio Basic
7.8.1 Bio Basic Company Information
7.8.2 Bio Basic Business Overview
7.8.3 Bio Basic Gene Fragment Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Bio Basic Gene Fragment Products Offered
7.8.5 Bio Basic Recent Development
7.9 BiOligo Biotechnology
7.9.1 BiOligo Biotechnology Company Information
7.9.2 BiOligo Biotechnology Business Overview
7.9.3 BiOligo Biotechnology Gene Fragment Sales, Revenue and Gross Margin (2020-2025)
7.9.4 BiOligo Biotechnology Gene Fragment Products Offered
7.9.5 BiOligo Biotechnology Recent Development
8 Gene Fragment Manufacturing Cost Analysis
8.1 Gene Fragment Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Gene Fragment
8.4 Gene Fragment Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Gene Fragment Distributors List
9.3 Gene Fragment Customers
10 Gene Fragment Market Dynamics
10.1 Gene Fragment Industry Trends
10.2 Gene Fragment Market Drivers
10.3 Gene Fragment Market Challenges
10.4 Gene Fragment Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Gene Fragment Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Gene Fragment Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Gene Fragment Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Gene Fragment Sales (Million bp) by Region (2020-2025)
Table 5. Global Gene Fragment Sales Market Share by Region (2020-2025)
Table 6. Global Gene Fragment Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Gene Fragment Revenue Share by Region (2020-2025)
Table 8. Global Gene Fragment Sales (Million bp) Forecast by Region (2026-2031)
Table 9. Global Gene Fragment Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Gene Fragment Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Gene Fragment Revenue Share Forecast by Region (2026-2031)
Table 12. Global Gene Fragment Sales by Type (Million bp) & (2020-2025)
Table 13. Global Gene Fragment Sales Share by Type (2020-2025)
Table 14. Global Gene Fragment Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Gene Fragment Price by Type (USD/bp) & (2020-2025)
Table 16. Global Gene Fragment Sales by Type (Million bp) & (2026-2031)
Table 17. Global Gene Fragment Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Gene Fragment Price by Type (USD/bp) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Gene Fragment Sales by Application (Million bp) & (2020-2025)
Table 21. Global Gene Fragment Sales Share by Application (2020-2025)
Table 22. Global Gene Fragment Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Gene Fragment Price by Application (USD/bp) & (2020-2025)
Table 24. Global Gene Fragment Sales by Application (Million bp) & (2026-2031)
Table 25. Global Gene Fragment Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Gene Fragment Price by Application (USD/bp) & (2026-2031)
Table 27. New Sources of Growth in Gene Fragment Application
Table 28. Global Gene Fragment Sales by Company (Million bp) & (2020-2025)
Table 29. Global Gene Fragment Sales Share by Company (2020-2025)
Table 30. Global Gene Fragment Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Gene Fragment Revenue Share by Company (2020-2025)
Table 32. Global Gene Fragment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Fragment as of 2024)
Table 33. Global Market Gene Fragment Average Price by Company (USD/bp) & (2020-2025)
Table 34. Global Key Manufacturers of Gene Fragment, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Gene Fragment, Product Type & Application
Table 36. Global Key Manufacturers of Gene Fragment, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Gene Fragment Sales by Company (2020-2025) & (Million bp)
Table 39. North America Gene Fragment Sales Market Share by Company (2020-2025)
Table 40. North America Gene Fragment Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Gene Fragment Revenue Market Share by Company (2020-2025)
Table 42. North America Gene Fragment Sales by Type (2020-2025) & (Million bp)
Table 43. North America Gene Fragment Sales Market Share by Type (2020-2025)
Table 44. North America Gene Fragment Sales by Application (2020-2025) & (Million bp)
Table 45. North America Gene Fragment Sales Market Share by Application (2020-2025)
Table 46. Europe Gene Fragment Sales by Company (2020-2025) & (Million bp)
Table 47. Europe Gene Fragment Sales Market Share by Company (2020-2025)
Table 48. Europe Gene Fragment Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Gene Fragment Revenue Market Share by Company (2020-2025)
Table 50. Europe Gene Fragment Sales by Type (2020-2025) & (Million bp)
Table 51. Europe Gene Fragment Sales Market Share by Type (2020-2025)
Table 52. Europe Gene Fragment Sales by Application (2020-2025) & (Million bp)
Table 53. Europe Gene Fragment Sales Market Share by Application (2020-2025)
Table 54. China Gene Fragment Sales by Company (2020-2025) & (Million bp)
Table 55. China Gene Fragment Sales Market Share by Company (2020-2025)
Table 56. China Gene Fragment Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Gene Fragment Revenue Market Share by Company (2020-2025)
Table 58. China Gene Fragment Sales by Type (2020-2025) & (Million bp)
Table 59. China Gene Fragment Sales Market Share by Type (2020-2025)
Table 60. China Gene Fragment Sales by Application (2020-2025) & (Million bp)
Table 61. China Gene Fragment Sales Market Share by Application (2020-2025)
Table 62. Integrated DNA Technologies Company Information
Table 63. Integrated DNA Technologies Description and Business Overview
Table 64. Integrated DNA Technologies Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp) and Gross Margin (2020-2025)
Table 65. Integrated DNA Technologies Gene Fragment Product
Table 66. Integrated DNA Technologies Recent Development
Table 67. Thermo Scientific Company Information
Table 68. Thermo Scientific Description and Business Overview
Table 69. Thermo Scientific Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp) and Gross Margin (2020-2025)
Table 70. Thermo Scientific Gene Fragment Product
Table 71. Thermo Scientific Recent Development
Table 72. Eurofins Scientific Company Information
Table 73. Eurofins Scientific Description and Business Overview
Table 74. Eurofins Scientific Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp) and Gross Margin (2020-2025)
Table 75. Eurofins Scientific Gene Fragment Product
Table 76. Eurofins Scientific Recent Development
Table 77. GenScript Biotech Company Information
Table 78. GenScript Biotech Description and Business Overview
Table 79. GenScript Biotech Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp) and Gross Margin (2020-2025)
Table 80. GenScript Biotech Gene Fragment Product
Table 81. GenScript Biotech Recent Development
Table 82. Azenta Life Sciences Company Information
Table 83. Azenta Life Sciences Description and Business Overview
Table 84. Azenta Life Sciences Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp) and Gross Margin (2020-2025)
Table 85. Azenta Life Sciences Gene Fragment Product
Table 86. Azenta Life Sciences Recent Development
Table 87. Twist Bioscience Company Information
Table 88. Twist Bioscience Description and Business Overview
Table 89. Twist Bioscience Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp) and Gross Margin (2020-2025)
Table 90. Twist Bioscience Gene Fragment Product
Table 91. Twist Bioscience Recent Development
Table 92. Synbio Technologies Company Information
Table 93. Synbio Technologies Description and Business Overview
Table 94. Synbio Technologies Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp) and Gross Margin (2020-2025)
Table 95. Synbio Technologies Gene Fragment Product
Table 96. Synbio Technologies Recent Development
Table 97. Bio Basic Company Information
Table 98. Bio Basic Description and Business Overview
Table 99. Bio Basic Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp) and Gross Margin (2020-2025)
Table 100. Bio Basic Gene Fragment Product
Table 101. Bio Basic Recent Development
Table 102. BiOligo Biotechnology Company Information
Table 103. BiOligo Biotechnology Description and Business Overview
Table 104. BiOligo Biotechnology Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp) and Gross Margin (2020-2025)
Table 105. BiOligo Biotechnology Gene Fragment Product
Table 106. BiOligo Biotechnology Recent Development
Table 107. Production Base and Market Concentration Rate of Raw Material
Table 108. Key Suppliers of Raw Materials
Table 109. Gene Fragment Distributors List
Table 110. Gene Fragment Customers List
Table 111. Gene Fragment Market Trends
Table 112. Gene Fragment Market Drivers
Table 113. Gene Fragment Market Challenges
Table 114. Gene Fragment Market Restraints
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Fragment Product Picture
Figure 2. Global Gene Fragment Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Gene Fragment Sales Market Share by Type in 2024 & 2031
Figure 4. 0-999 bp Product Picture
Figure 5. 1000-1999 bp Product Picture
Figure 6. 2000-3999 bp Product Picture
Figure 7. 4000+ bp Product Picture
Figure 8. Global Gene Fragment Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 9. Global Gene Fragment Sales Market Share by Application in 2024 & 2031
Figure 10. CRISPR-based Genome Editing Examples
Figure 11. Antibody Engineering Examples
Figure 12. Cloning Process Examples
Figure 13. Others Examples
Figure 14. Global Gene Fragment Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Gene Fragment Sales Growth Rate (2020-2031) & (US$ Million)
Figure 16. Global Gene Fragment Sales (Million bp) Growth Rate (2020-2031)
Figure 17. Global Gene Fragment Price Trends Growth Rate (2020-2031) & (USD/bp)
Figure 18. Gene Fragment Report Years Considered
Figure 19. Global Market Gene Fragment Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 20. Global Gene Fragment Revenue Market Share by Region: 2020 VS 2024
Figure 21. North America Gene Fragment Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. North America Gene Fragment Sales (Million bp) Growth Rate (2020-2031)
Figure 23. Europe Gene Fragment Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Europe Gene Fragment Sales (Million bp) Growth Rate (2020-2031)
Figure 25. China Gene Fragment Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. China Gene Fragment Sales (Million bp) Growth Rate (2020-2031)
Figure 27. Global Gene Fragment Revenue Share by Type (2020-2025)
Figure 28. Global Gene Fragment Sales Share by Type (2026-2031)
Figure 29. Global Gene Fragment Revenue Share by Type (2026-2031)
Figure 30. Global Gene Fragment Revenue Share by Application (2020-2025)
Figure 31. Global Gene Fragment Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Gene Fragment Sales Share by Application (2026-2031)
Figure 33. Global Gene Fragment Revenue Share by Application (2026-2031)
Figure 34. Global Gene Fragment Sales Share by Company (2024)
Figure 35. Global Gene Fragment Revenue Share by Company (2024)
Figure 36. Global 5 Largest Gene Fragment Players Market Share by Revenue in Gene Fragment: 2020 & 2024
Figure 37. Gene Fragment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Gene Fragment
Figure 39. Manufacturing Process Analysis of Gene Fragment
Figure 40. Gene Fragment Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
